TNF and Alzheimer disease: Finally, whether the coadministration of TNF-α inhibitors and the other drugs commonly prescribed in AD (including galantamine, rivastigmine, donepezil, memantine, and the recently approved monoclonal antibodies that bind to Aβ protofibrils, lecanemab, and aducanumab) is feasible is still unknown.